Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

Article type

Original Article


Article page

516-519


Authors Details

Premalatha T S, Sumangala G*, Geeta Acharya, Kiran Kulkarni, Vishakha Bidkar


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1623

PDF Downloaded: 712


Is preoperative CA-125 level a predictor of cytoreduction in carcinoma ovary?


Original Article

Author Details : Premalatha T S, Sumangala G*, Geeta Acharya, Kiran Kulkarni, Vishakha Bidkar

Volume : 5, Issue : 4, Year : 2018

Article Page : 516-519

https://doi.org/10.18231/2394-2754.2018.0116



Suggest article by email

Get Permission

Abstract

Optimal cyto-reduction of advanced EOC has profound impact on the survival and prognosis of patients3. Suboptimal cyto-reduction of advanced ovarian cancer is related to initial tumor bulk which indirectly correlates with serum CA125 levels. Can assessment of level of CA 125 in pre-opererative period predict optimal cyto-reduction is the aim of the study. The mean age of the 70 patients in this study was 49.9 years (SD- 11.75, Range: 21-69 years). Fourty four (63%) had stage III-?V disease. Sixty five (93%) patients had papillary serous ovarian cancer. The serum CA125 levels ranged from 6- 5300 U/ml with median pre-operative serum CA-125 level for all the patients being 259 U/ml (IQR- 682.98U/ml). The level was elevated (>35 U/ml) in 49% of patients with stage ?-? compared with 93% of patients with stage ? or ?V disease. Optimal tumor cyto-reduction was obtained in 61/70 cases (87%) of total patients and in 35/44 (80%) of patients with stage III-?V disease. Diaphragmatic stripping, appendecetomy, recto-sigmoid resection and anastomosis, pelvic peritonectomy, peritoneal stripping/ debulking of peritoneal disease, hemi-colectomy, ileo colic anastomosis and partial nephrectomy. Most of our patients were in intermediate surgical complexity category with a score between 4-7. In 9 patients all belonging to advanced stage, sub-optimal cyto-reduction was done due to multiple co-morbidities, multiple mesenteric lymphnode involvement, multiple small bowel and liver parenchymal deposits and patient not willing for colostomy. An ROC curve analysis showed threshold value of CA125 of 411U/ml. With a cut-off of 411U/ml, 97% of total patients with CA125 levels lower than 411U/ml were able to undergo optimal cyto-reduction. Also, in 76% of patients with CA125 level more than 411U/ml optimal cyto-reduction could be achieved. When only advanced stages (stage III-IV) were considered, with a cut-off of 411U/ml, 88% of patients with CA125 levels lower than 411U/ml were able to undergo optimal cyto-reduction. Also, in 73% of patients with CA125 level more than 411U/ml optimal cyto-reduction could be achieved. With a pre-operative cut-off value of CA125 more than 411U/ml, the sensitivity, that is, probability to predict sub-optimal cyto-reduction was 65% and specificity, that is, probability to predict optimal cyto-reduction was only 67%. Which showed poor predictability for resectability which was in concordance with other studies. Though it is difficult to draw definite conclus

Keywords: Carcinoma ovary, CA125, Cyto-reduction, Surgical complexicity score.


How to cite : Premalatha T S, Sumangala G, Acharya G , Kulkarni K, Bidkar V, Is preoperative CA-125 level a predictor of cytoreduction in carcinoma ovary?. Indian J Obstet Gynecol Res 2018;5(4):516-519

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.